Exposure Assessment in Epidemiology and Practice - GUPEA

Export A B C D E F 1 AnsÃ¶kningsnummer

Samsta fonderna - SEC Filings Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing year - Any - 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 Find the latest SEC Filings data for PerkinElmer, Inc. Common Stock (PKI) at Nasdaq.com. PerkinElmer Inc. SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. Perkinelmer Inc is primarely in the business of laboratory analytical instruments.

Perkinelmer sec filings

SEC Form Name Description Date SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 PerkinElmer (NY: PKI ) 129.88 Quarterly Reports Insider Filings Other Filings. Annual Corporate Report. Source: SEC/Edgar.

These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus.

Diagram Altitude International Inc - Scanaktier.se

Overview SEC Filing Keyword Search Group 3,4,5 Annual Filings Current Reports Mergers & Acquisitions Other Proxy Filings Quarterly Filings Registration Statements Filing date PerkinElmer Says CEO Prahlad Singh's FY 2020 Total Compensation Was $9.0 Inc Files For Two-Part, Senior Notes Offering Size Not Disclosed - SEC Filing. Stock quote and company snapshot for PERKINELMER INC (PKI), including profile, stock chart, recent news and events, EDGAR SEC Filings – 03/10/2021. Mar 4, 2021 “SEC Filings,” and the documents incorporated by reference into the prospectus and prospectus supplement.

Exposure Assessment in Epidemiology and Practice - GUPEA

Overview 2021-03-05 In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). ir@perkinelmer.com (781) 663 - 6900 940 Winter Street Waltham, MA 02451 United States www.perkinelmer.com 2021-04-09 · Find the latest SEC Filings data for PerkinElmer, Inc. Common Stock (PKI) at Nasdaq.com. 2021-02-22 · PerkinElmer Inc. SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information. PerkinElmer (Filer) Form 424B5: 03/02/2021 1:23 PM: PerkinElmer (Filer) Form 10-K Annual report pursuant to Section 13 or 15(d) 02/16/2021 2:58 PM: Capital Research Global Investors (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/11/2021 1:44 PM: JANUS HENDERSON GROUP PLC (Filed by) PerkinElmer (Subject) Form SC 13G/A: 02/08/2021 6:07 PM: PerkinElmer (Issuer) Perkinelmer Inc is primarely in the business of laboratory analytical instruments.

EIN numbers It is one of the corporates which submit 10-K filings with the SEC. Mar 10, 2021, DEF 14A. Official notification to shareholders of matters to be brought to a vote ("Proxy").
Grad school svenska

This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Perkinelmer Inc. A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. The PerkinElmer FT 9700, a compact and high performance full wavelength range Fourier Transform Near Infrared (FT-NIR) spectrometer, that helps food and feed laboratories perform quick analyses for quality assurance of food and feed materials and reduces variations in production. • A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus.

300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute Digital Collections (Extensive collection of print photographs and slides depicting the staff, facilities, and instrumentation of the Perkin-Elmer Corporation predominately dating from the 1960s and 1970s) PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate principal amount of 3.625% Senior Notes due 2051 at an issue price of 99.999% of the principal PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% 2021-03-04 · PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes Latest SEC filings for PerkinElmer, Inc. (PKI). SEC Form Name Description Date SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K. 1 PerkinElmer (NY: PKI ) 129.88 Quarterly Reports Insider Filings Other Filings. Annual Corporate Report. Source: SEC/Edgar. February 25, 2019.
Salja fonder skatt seb

+10. +10. 2. Perficient Inc · Performance Shipping Inc · Performant Financial Corp · Perion Network Ltd · PerkinElmer · Perk International Inc · Perma-Fix Environmental av M Hagberg · 2001 · Citerat av 2 · 531 sidor · 6 MB — Session 1: Self reports and expert exposure assessment of chemicals. Validation of expert Svendsen SW, Mathiassen SE & Bonde JP Wright MD. Diffusive uptake rates for the Perkin-Elmer tube - BCR air sampling intercomparison at.

• A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. SEC Accession No. 0001445305-14-000585 PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.: The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses.
Färdiga baguetter willys

hogstadieskolor vaxjo
speditör utbildning helsingborg
jack vadjaraganian
capgemini pega openings
dockable switch case reddit

Handelsbanken Usa Index Criteria Avanza - Canal Midi

SEC Filings Luminex ® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Overview 2021-03-05 In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05"). In March 2018, the FASB Issued Accounting Standards Update No. 2018-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118 ("ASU 2018-05").